DNA vaccines: Developing new strategies to enhance immune responses

Immunologic Research

Volumn 42, Issue 1-3, 2008, Pages 219-232

  Abdulhaqq, Shaheed A ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Chemokines; Codon RNA optimization; Consensus immunogens; Cytokines; DNA vaccination; Electroporation; Plasmid

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERFERON; COLONY STIMULATING FACTOR 1; DNA VACCINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INACTIVATED VIRUS VACCINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7; INTERLEUKIN 8; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; RANTES; RIBAVIRIN; SECONDARY LYMPHOID TISSUE CHEMOKINE; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; IMMUNOLOGICAL ADJUVANT; VIRUS VACCINE;

ADJUVANT THERAPY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AVIAN INFLUENZA; CELLULAR IMMUNITY; CHIKUNGUNYA ALPHAVIRUS; CODON; CROSS REACTION; DENDRITIC CELL; DNA IMMUNIZATION; DNA TRANSFECTION; DNA VECTOR; DRUG DELIVERY SYSTEM; ELECTROPORATION; HEALTH; HEPATITIS C; HEPATITIS C VIRUS; HERPES VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; IN VIVO STUDY; INFLUENZA; INFLUENZA VIRUS A H5N1; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIMIAN IMMUNODEFICIENCY VIRUS; TH1 CELL; TH2 CELL; VIREMIA; VIRUS INFECTION; ANIMAL; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; METHODOLOGY; VIRUS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; GENETIC VECTORS; HUMANS; TRANSFECTION; VACCINES, DNA; VIRAL VACCINES; VIRUS DISEASES; VIRUSES;

EID: 61849159893     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8076-3     Document Type: Review

References (87)

1. J Stasney KE Paschkis A Cantarow HP Morris 1955 The production of neoplasms by the injection of chromatin fractions Acta Unio Int Contra Cancrum 11 6 715 20 13326681 1:STN:280:CymD2sbislc%3D
2. Y Ito 1961 Heat-resistance of the tumorigenic nucleic acid of shope papillomatosis Proc Natl Acad Sci USA 47 12 1897 900 16578520 10.1073/pnas.47.12.1897 1:CAS:528:DyaF38Xmtlenug%3D%3D
3. MA Liu JB Ulmer 2000 Gene-based vaccines Mol Ther 1 6 497 500 10933973 10.1006/mthe.2000.0079 1:CAS:528:DC%2BD38XhvF2hsbY%3D
4. H Will R Cattaneo HG Koch G Darai H Schaller H Schellekens PM van Eerd F Deinhardt 1982 Cloned HBV DNA causes hepatitis in chimpanzees Nature 299 5885 740 2 7121604 10.1038/299740a0 1:CAS:528:DyaL3sXht1ektb0%3D (Pubitemid 12037761)
5. N Benvenisty L Reshef 1986 Direct introduction of genes into rats and expression of the genes Proc Natl Acad Sci USA 83 24 9551 5 3540943 10.1073/pnas.83.24.9551 1:CAS:528:DyaL2sXnvFGrtg%3D%3D
6. C Seeger D Ganem HE Varmus 1984 The cloned genome of ground squirrel hepatitis virus is infectious in the animal Proc Natl Acad Sci USA 81 18 5849 52 6091114 10.1073/pnas.81.18.5849 1:CAS:528:DyaL2cXmtVGhu7c%3D
7. C Nicolau A Le Pape P Soriano F Fargette MF Juhel 1983 In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I Proc Natl Acad Sci USA 80 4 1068 72 6341988 10.1073/pnas.80.4.1068 1:CAS:528:DyaL3sXhtlahurg%3D
8. PL Felgner TR Gadek M Holm R Roman HW Chan M Wenz JP Northrop GM Ringold M Danielsen 1987 Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc Natl Acad Sci USA 84 21 7413 7 2823261 10.1073/pnas.84.21.7413 1:CAS:528:DyaL1cXjtlSgug%3D%3D
9. TW Dubensky BA Campbell LP Villarreal 1984 Direct transfection of viral and plasmid DNA into the liver or spleen of mice Proc Natl Acad Sci USA 81 23 7529 33 6095303 10.1073/pnas.81.23.7529 1:CAS:528:DyaL2MXntlGjtw%3D%3D (Pubitemid 15196216)
10. JA Wolff RW Malone P Williams W Chong G Acsadi A Jani PL Felgner 1990 Direct gene transfer into mouse muscle in vivo Science 247 4949 Pt 1 1465 8 1690918 10.1126/science.1690918 1:CAS:528:DyaK3cXhslemsbg%3D
11. DC Tang M DeVit SA Johnston 1992 Genetic immunization is a simple method for eliciting an immune response Nature 356 6365 152 4 1545867 10.1038/356152a0 1:CAS:528:DyaK38XhslWkt7w%3D
12. JB Ulmer JJ Donnelly SE Parker GH Rhodes PL Felgner VJ Dwarki SH Gromkowski RR Deck CM DeWitt A Friedman, et al. 1993 Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 5102 1745 9 8456302 10.1126/science.8456302 1:CAS:528:DyaK3sXitFSqtrk%3D
13. EF Fynan RG Webster DH Fuller JR Haynes JC Santoro HL Robinson 1993 DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations Proc Natl Acad Sci USA 90 24 11478 82 8265577 10.1073/pnas.90.24. 11478 1:CAS:528:DyaK2cXos1WqtA%3D%3D (Pubitemid 24008662)
14. B Wang KE Ugen V Srikantan MG Agadjanyan K Dang Y Refaeli AI Sato J Boyer WV Williams DB Weiner 1993 Gene inoculation generates immune responses against human immunodeficiency virus type 1 Proc Natl Acad Sci USA 90 9 4156 60 8483929 10.1073/pnas.90.9.4156 1:CAS:528:DyaK3sXktVSgt7Y%3D
15. RE Hawkins G Winter TJ Hamblin FK Stevenson SJ Russell 1993 A genetic approach to idiotypic vaccination J Immunother Emphasis Tumor Immunol 14 4 273 8 8280708 1:STN:280:ByuC3cjos1c%3D
16. M Dupuis K Denis-Mize C Woo C Goldbeck MJ Selby M Chen GR Otten JB Ulmer JJ Donnelly G Ott, et al. 2000 Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice J Immunol 165 5 2850 8 10946318 1:CAS:528:DC%2BD3cXmtFOru7c%3D
17. MA Chattergoon JJ Kim JS Yang TM Robinson DJ Lee T Dentchev DM Wilson V Ayyavoo DB Weiner 2000 Targeted antigen delivery to antigen-presenting cells including dendritic cells by engineered Fas-mediated apoptosis Nat Biotechnol 18 9 974 9 10973219 10.1038/79470 1:CAS:528:DC%2BD3cXmt1yrsrs%3D (Pubitemid 32977379)
18. A Rubartelli A Poggi MR Zocchi 1997 The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium Eur J Immunol 27 8 1893 900 9295024 10.1002/eji.1830270812 1:CAS:528:DyaK2sXltlCis70%3D (Pubitemid 27346003)
19. ML Albert SF Pearce LM Francisco B Sauter P Roy RL Silverstein N Bhardwaj 1998 Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes J Exp Med 188 7 1359 68 9763615 10.1084/jem.188.7.1359 1:CAS:528:DyaK1cXmsFals78%3D (Pubitemid 28478024)
20. LA Harshyne MI Zimmer SC Watkins SM Barratt-Boyes 2003 A role for class A scavenger receptor in dendritic cell nibbling from live cells J Immunol 170 5 2302 9 12594251 1:CAS:528:DC%2BD3sXht12hsLg%3D
21. RM Steinman M Pope 2002 Exploiting dendritic cells to improve vaccine efficacy J Clin Invest 109 12 1519 26 12070296 1:CAS:528:DC%2BD38Xks12ltLw%3D
22. JR Mascola A Sambor K Beaudry S Santra B Welcher MK Louder TC Vancott Y Huang BK Chakrabarti WP Kong, et al. 2005 Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins J Virol 79 2 771 9 15613305 10.1128/JVI.79.2.771-779.2005 1:CAS:528:DC%2BD2MXlt12isg%3D%3D (Pubitemid 40053860)
23. H Hemmi O Takeuchi T Kawai T Kaisho S Sato H Sanjo M Matsumoto K Hoshino H Wagner K Takeda, et al. 2000 A Toll-like receptor recognizes bacterial DNA Nature 408 6813 740 5 11130078 10.1038/35047123 1:CAS:528:DC%2BD3cXptVCqsL0%3D (Pubitemid 32015992)
24. D Tudor C Dubuquoy V Gaboriau F Lefevre B Charley S Riffault 2005 TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines Vaccine 23 10 1258 64 15652668 10.1016/j.vaccine.2004.09.001 1:CAS:528: DC%2BD2MXkslOmtw%3D%3D (Pubitemid 40126529)
25. L Zhang Y Yang X Yang J Zhao J Yang F Liu Z Zhang G Wu C Su 2008 T cell epitope-based peptide-DNA dual vaccine induces protective immunity against Schistosoma japonicum infection in C57BL/6 J mice Microbes Infect 10 3 251 9 18316223 10.1016/j.micinf.2007.11.009 1:CAS:528:DC%2BD1cXktFelsrk%3D
26. Y Zhu J Ren DA Harn J Si C Yu X Ming Y Liang 2003 Protective immunity induced with 23 kDa membrane protein dna vaccine of Schistosoma japonicum Chinese strain in infected C57BL/6 mice Southeast Asian J Trop Med Public Health 34 4 697 701 15115073 1:CAS:528:DC%2BD2cXkt1Kntbo%3D
27. ZY Yang WP Kong Y Huang A Roberts BR Murphy K Subbarao GJ Nabel 2004 A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice Nature 428 6982 561 4 15024391 10.1038/nature02463 1:CAS:528: DC%2BD2cXis1GksL4%3D (Pubitemid 38480539)
28. Y Zhu J Si DA Ham C Yu W He W Hua X Yin Y Liang M Xu R Xu 2002 The protective immunity produced in infected C57BL/6 mice of a DNA vaccine encoding Schistosoma japonicum Chinese strain triose-phosphate isomerase Southeast Asian J Trop Med Public Health 33 2 207 13 12236413 1:CAS:528:DC%2BD3sXptVKkug%3D%3D
29. S Kodihalli H Goto DL Kobasa S Krauss Y Kawaoka RG Webster 1999 DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice J Virol 73 3 2094 8 9971791 1:CAS:528:DyaK1MXhvVWnsb0%3D
30. DR Casimiro L Chen TM Fu RK Evans MJ Caulfield ME Davies A Tang M Chen L Huang V Harris, et al. 2003 Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene J Virol 77 11 6305 13 12743287 10.1128/JVI.77.11.6305-6313.2003 1:CAS:528:DC%2BD3sXktV2nsrw%3D (Pubitemid 36588400)
31. DA Hokey DB Weiner 2006 DNA vaccines for HIV: challenges and opportunities Springer Semin Immunopathol 28 3 267 79 17031649 10.1007/s00281-006-0046-z 1:CAS:528:DC%2BD28Xht1WhsbnN (Pubitemid 44764282)
32. DJ Laddy J Yan N Corbitt D Kobasa GP Kobinger DB Weiner 2007 Immunogenicity of novel consensus-based DNA vaccines against avian influenza Vaccine 25 16 2984 9 17306909 10.1016/j.vaccine.2007.01.063 1:CAS:528: DC%2BD2sXjslSrsro%3D (Pubitemid 46482729)
33. KA Schoenly DB Weiner 2008 Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business" J Virol 82 7 3166 80 17989174 10.1128/JVI.01634-07 1:CAS:528:DC%2BD1cXjvFensrs%3D
34. H Grosjean W Fiers 1982 Preferential codon usage in prokaryotic genes: the optimal codon-anticodon interaction energy and the selective codon usage in efficiently expressed genes Gene 18 3 199 209 6751939 10.1016/0378-1119(82) 90157-3 1:CAS:528:DyaL38XmtV2ntr0%3D (Pubitemid 13232993)
35. HJ Ko SY Ko YJ Kim EG Lee SN Cho CY Kang 2005 Optimization of codon usage enhances the immunogenicity of a DNA vaccine encoding mycobacterial antigen Ag85B Infect Immun 73 9 5666 74 16113284 10.1128/IAI.73.9.5666-5674.2005 1:CAS:528:DC%2BD2MXps1Gkt7w%3D (Pubitemid 41193002)
36. T Nagata M Uchijima A Yoshida M Kawashima Y Koide 1999 Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms Biochem Biophys Res Commun 261 2 445 51 10425204 10.1006/bbrc.1999.1050 1:CAS:528:DyaK1MXks1OrsL4%3D (Pubitemid 29392495)
37. AS Fauci 2006 Pandemic influenza threat and preparedness Emerg Infect Dis 12 1 73 7 16494721
38. GA Elmowalid M Qiao SH Jeong BB Borg TF Baumert RK Sapp Z Hu K Murthy TJ Liang 2007 Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees Proc Natl Acad Sci USA 104 20 8427 32 17485666 10.1073/pnas.0702162104 1:CAS:528:DC%2BD2sXmtVChtr8%3D (Pubitemid 47175504)
39. MJ Choi JH Kim HI Maibach 2006 Topical DNA vaccination with DNA/Lipid based complex Curr Drug Deliv 3 1 37 45 16472092 10.2174/156720106775197484 1:CAS:528:DC%2BD28XktlCjuw%3D%3D
40. K Hamajima S Sasaki J Fukushima T Kaneko KQ Xin I Kudoh K Okuda 1998 Intranasal administration of HIV-DNA vaccine formulated with a polymer, carboxymethylcellulose, augments mucosal antibody production and cell-mediated immune response Clin Immunol Immunopathol 88 2 205 10 9714699 10.1006/clin.1998.4566 1:CAS:528:DyaK1cXlvVyktLk%3D (Pubitemid 28397345)
41. CJ Pachuk RB Ciccarelli M Samuel ME Bayer RD Troutman DV Zurawski JI Schauer TJ Higgins DB Weiner DM Sosnoski, et al. 2000 Characterization of a new class of DNA delivery complexes formed by the local anesthetic bupivacaine Biochim Biophys Acta 1468 1-2 20 30 11018648 1:CAS:528:DC%2BD3cXmvFyqs74%3D
42. CK Tang J Lodding G Minigo DS Pouniotis M Plebanski A Scholzen IF McKenzie GA Pietersz V Apostolopoulos 2007 Mannan-mediated gene delivery for cancer immunotherapy Immunology 120 3 325 35 17328786 10.1111/j.1365-2567.2006. 02506.x 1:CAS:528:DC%2BD2sXisVyltrs%3D (Pubitemid 46232907)
43. DH Fuller P Loudon C Schmaljohn 2006 Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases Methods 40 1 86 97 16997717 10.1016/j.ymeth.2006.05.022 1:CAS:528:DC%2BD28XpvFGhsrk%3D (Pubitemid 44419542)
44. SS Rao P Gomez JR Mascola V Dang GR Krivulka F Yu CI Lord L Shen R Bailer GJ Nabel, et al. 2006 Comparative evaluation of three different intramuscular delivery methods for DNA immunization in a nonhuman primate animal model Vaccine 24 3 367 73 16194587 10.1016/j.vaccine.2005.07.072 1:CAS:528:DC%2BD2MXhtlaitL3K (Pubitemid 41790440)
45. M Tarek 2005 Membrane electroporation: a molecular dynamics simulation Biophys J 88 6 4045 53 15764667 10.1529/biophysj.104.050617 1:CAS:528: DC%2BD2MXksl2jtrg%3D (Pubitemid 40991116)
46. DP Tieleman 2004 The molecular basis of electroporation BMC Biochem 5 10 15260890 10.1186/1471-2091-5-10
47. MP Murtaugh DL Foss 2002 Inflammatory cytokines and antigen presenting cell activation Vet Immunol Immunopathol 87 3-4 109 21 12072225 10.1016/S0165-2427(02)00042-9 1:CAS:528:DC%2BD38XksFKktLs%3D (Pubitemid 34665229)
48. J Liu R Kjeken I Mathiesen DH Barouch 2008 Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation J Virol 82 11 5643 9 18353952 10.1128/JVI.02564-07 1:CAS:528:DC%2BD1cXmt1Slsbk%3D (Pubitemid 351705271)
49. LA Hirao L Wu AS Khan DA Hokey J Yan A Dai MR Betts R Draghia-Akli DB Weiner 2008 Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques Vaccine 26 25 3112 20 18430495 10.1016/j.vaccine.2008.02.036 1:CAS:528:DC%2BD1cXnt1Sktbo%3D
50. DJ Laddy J Yan M Kutzler D Kobasa GP Kobinger AS Khan J Greenhouse NY Sardesai R Draghia-Akli DB Weiner 2008 Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens PLoS ONE 3 6 e2517 18575608 10.1371/journal.pone.0002517
51. Muthumani K, Lankaraman KM, Laddy DJ, Sundaram SG, Chung CW, Sako E, Wu L, Khan A, Sardesai N, Kim JJ et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine 2008.
52. LA Hirao L Wu AS Khan A Satishchandran R Draghia-Akli DB Weiner 2008 Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques Vaccine 26 3 440 8 18082294 10.1016/j.vaccine.2007.10.041 1:CAS:528:DC%2BD1cXivFWktg%3D%3D
53. JY Scheerlinck 2001 Genetic adjuvants for DNA vaccines Vaccine 19 17-19 2647 56 11257404 10.1016/S0264-410X(00)00495-3 1:CAS:528:DC%2BD3MXitVOitrs%3D (Pubitemid 32234284)
54. CS Hsieh SE Macatonia CS Tripp SF Wolf A O'Garra KM Murphy 1993 Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages Science 260 5107 547 9 8097338 10.1126/science.8097338 1:CAS:528:DyaK3sXitlajsLg%3D
55. RA Seder R Gazzinelli A Sher WE Paul 1993 Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming Proc Natl Acad Sci USA 90 21 10188 92 7901851 10.1073/pnas.90.21.10188 1:CAS:528:DyaK2cXlt1eitg%3D%3D (Pubitemid 23328277)
56. JJ Kim V Ayyavoo ML Bagarazzi MA Chattergoon K Dang B Wang JD Boyer DB Weiner 1997 In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen J Immunol 158 2 816 26 8992999 1:CAS:528:DyaK2sXmtFKhtA%3D%3D
57. JI Sin JJ Kim RL Arnold KE Shroff D McCallus C Pachuk SP McElhiney MW Wolf SJ Pompa-de Bruin TJ Higgins, et al. 1999 IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge J Immunol 162 5 2912 21 10072541 1:CAS:528:DyaK1MXhtlyjtbs%3D
58. KS Schluns KD Klonowski L Lefrancois 2004 Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells Blood 103 3 988 94 14512307 10.1182/blood-2003-08-2814 1:CAS:528:DC%2BD2cXhtVaksrk%3D (Pubitemid 38129561)
59. JD Boyer TM Robinson MA Kutzler G Vansant DA Hokey S Kumar R Parkinson L Wu MK Sidhu GN Pavlakis, et al. 2007 Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid Proc Natl Acad Sci USA 104 47 18648 53 18000037 10.1073/pnas.0709198104 1:CAS:528:DC%2BD2sXhtl2ku7bM (Pubitemid 350210751)
60. JJ Kim LK Nottingham JI Sin A Tsai L Morrison J Oh K Dang Y Hu K Kazahaya M Bennett, et al. 1998 CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines J Clin Invest 102 6 1112 24 9739045 10.1172/JCI3986 1:CAS:528:DyaK1cXmtFyhsLo%3D
61. J Sin JJ Kim C Pachuk C Satishchandran DB Weiner 2000 DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo J Virol 74 23 11173 80 11070014 10.1128/JVI.74.23.11173-11180.2000 1:CAS:528:DC%2BD3MXitFWmtbg%3D (Pubitemid 32223984)
62. JD Boyer KE Ugen M Chattergoon B Wang A Shah M Agadjanyan ML Bagarazzi A Javadian R Carrano L Coney, et al. 1997 DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees J Infect Dis 176 6 1501 9 9395361 1:CAS:528:DyaK2sXnslOrtL4%3D
63. JD Boyer KE Ugen B Wang M Agadjanyan L Gilbert ML Bagarazzi M Chattergoon P Frost A Javadian WV Williams, et al. 1997 Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination Nat Med 3 5 526 32 9142121 10.1038/nm0597-526 1:CAS:528:DyaK2sXivFOmsL8%3D
64. JD Boyer B Wang KE Ugen M Agadjanyan A Javadian P Frost K Dang RA Carrano R Ciccarelli L Coney, et al. 1996 In vivo protective anti-HIV immune responses in non-human primates through DNA immunization J Med Primatol 25 3 242 50 8892046 1:CAS:528:DyaK28XlvFOjsLk%3D
65. B Wang J Boyer V Srikantan K Ugen L Gilbert C Phan K Dang M Merva MG Agadjanyan M Newman, et al. 1995 Induction of humoral and cellular immune responses to the human immunodeficiency type 1 virus in nonhuman primates by in vivo DNA inoculation Virology 211 1 102 12 7645204 10.1006/viro.1995.1383 1:CAS:528:DyaK2MXntlWjs74%3D
66. RR MacGregor JD Boyer KE Ugen KE Lacy SJ Gluckman ML Bagarazzi MA Chattergoon Y Baine TJ Higgins RB Ciccarelli, et al. 1998 First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response J Infect Dis 178 1 92 100 9652427 1:CAS:528:DyaK1cXksVSlt7w%3D
67. RR MacGregor JD Boyer RB Ciccarelli RS Ginsberg DB Weiner 2000 Safety and immune responses to a DNA-based human immunodeficiency virus (HIV) type I env/rev vaccine in HIV-infected recipients: follow-up data J Infect Dis 181 1 406 10608800 10.1086/315199 1:STN:280:DC%2BD3c%2FoslSntQ%3D%3D (Pubitemid 30049081)
68. JD Boyer B Nath K Schumann E Curley K Manson J Kim DB Weiner 2002 IL-4 increases Simian immunodeficiency virus replication despite enhanced SIV immune responses in infected rhesus macaques Int J Parasitol 32 5 543 50 11943227 10.1016/S0020-7519(01)00355-1 1:CAS:528:DC%2BD38Xis1eisLY%3D (Pubitemid 34273805)
69. JH Strauss EG Strauss 1994 The alphaviruses: gene expression, replication, and evolution Microbiol Rev 58 3 491 562 7968923 1:CAS:528:DyaK2cXmsFSlu7s%3D
70. AM Powers CH Logue 2007 Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus J Gen Virol 88 Pt 9 2363 77 17698645 10.1099/vir.0.82858-0 1:CAS:528:DC%2BD2sXhtVWnu7zE (Pubitemid 47323881)
71. C Korteweg J Gu 2008 Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans Am J Pathol 172 5 1155 70 18403604 10.2353/ajpath.2008.070791 1:CAS:528:DC%2BD1cXmtFOnt7Y%3D (Pubitemid 351671530)
72. K Ungchusak P Auewarakul SF Dowell R Kitphati W Auwanit P Puthavathana M Uiprasertkul K Boonnak C Pittayawonganon NJ Cox, et al. 2005 Probable person-to-person transmission of avian influenza A (H5N1) N Engl J Med 352 4 333 40 15668219 10.1056/NEJMoa044021 1:CAS:528:DC%2BD2MXnvVKgtA%3D%3D
73. D Normile 2006 Avian influenza. Human transmission but no pandemic in Indonesia Science 312 5782 1855 10.1126/science.312.5782.1864
74. MA Kutzler TM Robinson MA Chattergoon DK Choo AY Choo PY Choe MP Ramanathan R Parkinson S Kudchodkar Y Tamura, et al. 2005 Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help J Immunol 175 1 112 23 15972637 1:CAS:528:DC%2BD2MXltlynt7Y%3D
75. KA Lang DB Weiner 2000 HCV immunotherapies Expert Rev Vaccines 7 7 915 23 10.1586/14760584.7.7.915
76. KA Lang J Yan DB Weiner 2008 Strong HCV NS3- and NS4A- Specific cellular immune responses induced in mice and rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine Vaccine 26 49 6225 31 18692108 10.1016/j.vaccine. 2008.07.052 1:CAS:528:DC%2BD1cXhtlCru77P
77. JJ Kim JS Yang L Montaner DJ Lee AA Chalian DB Weiner 2000 Coimmunization with IFN-gamma or IL-2, but not IL-13 or IL-4 cDNA can enhance Th1-type DNA vaccine-induced immune responses in vivo J Interferon Cytokine Res 20 3 311 9 10762079 10.1089/107999000312450 1:CAS:528:DC%2BD3cXit1ensrY%3D (Pubitemid 30169743)
78. JJ Kim NN Trivedi LK Nottingham L Morrison A Tsai Y Hu S Mahalingam K Dang L Ahn NK Doyle, et al. 1998 Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens Eur J Immunol 28 3 1089 103 9541605 10.1002/(SICI)1521- 4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L 1:CAS:528: DyaK1cXhvFGitL0%3D (Pubitemid 28116223)
79. JI Sin J Kim C Pachuk DB Weiner 2000 Interleukin 7 can enhance antigen-specific cytotoxic-T-lymphocyte and/or Th2-type immune responses in vivo Clin Diagn Lab Immunol 7 5 751 8 10973449 10.1128/CDLI.7.5.751-758.2000 1:CAS:528:DC%2BD3cXntVCjsb0%3D (Pubitemid 30695512)
80. R Halwani JD Boyer B Yassine-Diab EK Haddad TM Robinson S Kumar R Parkinson L Wu MK Sidhu R Phillipson-Weiner, et al. 2008 Therapeutic vaccination with simian immunodeficiency virus (SIV)-DNA + IL-12 or IL-15 induces distinct CD8 memory subsets in SIV-infected macaques J Immunol 180 12 7969 79 18523260 1:CAS:528:DC%2BD1cXntVemu70%3D
81. MA Chattergoon V Saulino JP Shames J Stein LJ Montaner DB Weiner 2004 Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice Vaccine 22 13-14 1744 50 15068858 10.1016/j.vaccine.2004.01.036 1:CAS:528:DC%2BD2cXivVGjs7k%3D (Pubitemid 38447223)
82. JJ Kim LK Nottingham A Tsai DJ Lee HC Maguire J Oh T Dentchev KH Manson MS Wyand MG Agadjanyan, et al. 1999 Antigen-specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN-gamma, IL-12, or IL-18 gene adjuvants J Med Primatol 28 4-5 214 23 10593488 1:CAS:528:DyaK1MXnvVartLs%3D
83. JJ Kim JS Yang DJ Lee DM Wilson LK Nottingham L Morrison A Tsai J Oh K Dang T Dentchev, et al. 2000 Macrophage colony-stimulating factor can modulate immune responses and attract dendritic cells in vivo Hum Gene Ther 11 2 305 21 10680844 10.1089/10430340050016049 1:CAS:528:DC%2BD3cXhtVamtrc%3D (Pubitemid 30080388)
84. JJ Kim A Tsai LK Nottingham L Morrison DM Cunning J Oh DJ Lee K Dang T Dentchev AA Chalian, et al. 1999 Intracellular adhesion molecule-1 modulates beta-chemokines and directly costimulates T cells in vivo J Clin Invest 103 6 869 77 10079108 10.1172/JCI6024 1:CAS:528:DyaK1MXhvFarsr0%3D
85. JI Sin JJ Kim D Zhang DB Weiner 2001 Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T cell-mediated protective immunity against herpes simplex virus type 2 in vivo Hum Gene Ther 12 9 1091 102 11399230 10.1089/104303401750214302 1:CAS:528:DC%2BD3MXksFCqu7o%3D (Pubitemid 32692424)
86. JJ Kim LK Nottingham DM Wilson ML Bagarazzi A Tsai LD Morrison A Javadian AA Chalian MG Agadjanyan DB Weiner 1998 Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes Vaccine 16 19 1828 35 9795388 10.1016/S0264-410X(98)00177-7 1:CAS:528:DyaK1cXntVOht7k%3D (Pubitemid 28473923)
87. MG Agadjanyan MA Chattergoon MJ Holterman B Monzavi-Karbassi JJ Kim T Dentchev D Wilson V Ayyavoo LJ Montaner T Kieber-Emmons, et al. 2003 Costimulatory molecule immune enhancement in a plasmid vaccine model is regulated in part through the Ig constant-like domain of CD80/86 J Immunol 171 8 4311 9 14530356 1:CAS:528:DC%2BD3sXnvVOkt7c%3D